Frequency Therapeutics (FREQ) shares plunge 73% after FX-322's four-dose regime fails to improve hearing loss
23 March 2021 - 11:42PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Frequency Therapeutics (NASDAQ:FREQ)
Historical Stock Chart
From Apr 2024 to May 2024
Frequency Therapeutics (NASDAQ:FREQ)
Historical Stock Chart
From May 2023 to May 2024